Confusing Price With Safety

Bryan A. Liang, MD, PhD, JD

We all try to do our best, but even those in public service don't always get it right.  This seems to be the case when it comes to drug importation.  Supporters think that simply because drugs are purchased from "safe" countries as Canada and Britain, they are actually made there and are subject to strict health regulations and oversight.  But this is a dangerous misconception.

[...]

Regulating Online Pharmacies

Bryan A. Liang, MD, PhD, JD

According to some sources, there are at least 1,000 Web sites selling prescription drugs. Of course, not all of which are legitimate.  Considering the sheer number of hits an Internet search for "online pharmacy" returns, it's not surprising that the U.S. Senate has put the Online Pharmacy Consumer Protection Act of 2007 on its legislative calendar.  

[...]

Straight from the Horse’s Mouth

Yesterday's congressional hearing on the FDA's ability to guarantee the safety of our country's drug supply sounded another alarm that real consumer-protection measures need to be put in place that focus on patient safety. Let's hope Congress doesn't hit the snooze button again. It's been 9 years since the Government Accountability Office (GAO) last issued…

[...]